V VISISURE
LIVE

Serial Number

79420330

Owner

Novartis AG

Attorney

Maury M. Tepper, III

Filing Date

Feb 12, 2025

Add to watchlist:

No watchlists yet
View on USPTO

V VISISURE Trademark

Serial Number: 79420330 • Registration: 7979973

V VISISURE is a trademark filed by Novartis AG on February 12, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Novartis AG (13 trademarks)

CH-4002 Basel

Entity Type: 03

Trademark Details

Filing Date

February 12, 2025

Registration Date

October 14, 2025

Published for Opposition

August 26, 2025

Goods & Services

Medical injection devices sold empty

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Jun 18, 2026 FINV
FINAL DISPOSITION NOTICE SENT TO IB
Apr 24, 2026 FICS
FINAL DISPOSITION PROCESSED
Apr 24, 2026 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 14, 2026 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Oct 14, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Oct 14, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 26, 2025 NPUB
PUBLISHED FOR OPPOSITION
Aug 26, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 20, 2025 NONP
WITHDRAWN FROM PUB - OG REVIEW QUERY
Aug 5, 2025 PBCR
REFUSAL PROCESSED BY IB
Jul 19, 2025 RFNT
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 8, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 7, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 7, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 7, 2025 TROA
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 22, 2025 RFCS
REFUSAL PROCESSED BY MPU
Jun 21, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 20, 2025 RFCR
NON-FINAL ACTION WRITTEN
Apr 19, 2025 CNRT
ASSIGNED TO EXAMINER
Apr 19, 2025 DOCK
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Apr 4, 2025 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 4, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 4, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 4, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 4, 2025 COAR
APPLICATION FILING RECEIPT MAILED
Mar 31, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 31, 2025 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Mar 28, 2025 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Mar 27, 2025 SDRC